SCOTUS Weighs Medicaid Recipients’ Right to Sue
Side Effects Public Media Reporter Farah Yousry discusses the Supreme Court case challenging whether Medicaid recipients can continue to use a legal pathway to enforce their rights.
Read MoreSide Effects Public Media Reporter Farah Yousry discusses the Supreme Court case challenging whether Medicaid recipients can continue to use a legal pathway to enforce their rights.
Read MoreThere’s a severe shortage of people to care for older Americans. Could providing workers with new career pathways be part of the solution?
Read MoreJasmine Travers share new research that explores the effect of state vaccine mandates on vaccination rates and staffing changes in nursing homes.
Read MoreYaa Akosa Antwi shares research on nursing home deaths during COVID suggesting even well-intentioned policies can have unintended consequences.
Read MoreJasmine Travers shares research showing how racial biases can impact care for Black nursing home residents with advanced dementia.
Read MoreRachel Werner on new research exploring how nursing homes with private equity investment compared to other nursing homes on cost, outcomes and staffing.
Read MoreHow is the pharmaceutical industry reacting to the FDA’s surprising approval of a controversial Alzheimer’s drug?
Read MoreA costly new Alzheimer’s drug could wreak financial havoc on insurers, seniors and taxpayers.
Read MoreThe Aducanumab Aftermath A SPECIAL CONVERSATION SERIES June 22, 2021 Art by Leslie Walker About this Special Series The U.S. Food and Drug Administration (FDA) recently approved the costly new Alzheimer’s drug aducanumab (now known by the brand name Aduhelm) despite doubts about its safety and efficacy. Priced at $56,000 by drugmaker Biogen, aducanumab could…
Read More